Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Escalating Phase I Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PDC31 in Patients With Primary Dysmenorrhea

NCT01250587 is registered in ClinicalTrials.gov with PDC Biotech GmbH as lead sponsor.

NCT NCT01250587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01250587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Escalating Phase I Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PDC31 in Patients With Primary Dysmenorrhea
Lead sponsor
PDC Biotech GmbH
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2010
Completion date
June 30, 2012
Enrollment
24 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dysmenorrhea